ALLO - Allogene Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$6.43
DETAILS
HIGH:
$9.00
LOW:
$3.85
MEDIAN:
$6.42
CONSENSUS:
$6.43
UPSIDE:
221.50%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-04-21 | Yoshiyama Annie | officer: SVP, Finance | SELL | 9,586 | $2.31 | $22K |
| 2026-03-31 | Beneski Benjamin Machinas | officer: SVP, Chief Technical Officer | SELL | 2,867 | $2.50 | $7K |
| 2026-03-16 | Beneski Benjamin Machinas | officer: SVP, Chief Technical Officer | SELL | 4,835 | $2.47 | $12K |
| 2026-03-16 | Chang David D | director, officer: President and CEO | SELL | 47,763 | $2.47 | $118K |
| 2026-03-02 | Beneski Benjamin Machinas | officer: SVP, Chief Technical Officer | SELL | 7,132 | $2.60 | $19K |
| 2026-02-02 | Beneski Benjamin Machinas | officer: SVP, Chief Technical Officer | SELL | 7,549 | $1.73 | $13K |
| 2026-02-02 | Beneski Benjamin Machinas | officer: SVP, Chief Technical Officer | A-Award | 105,720 | -- | -- |
| 2026-02-02 | Chang David D | director, officer: President and CEO | SELL | 95,269 | $1.80 | $171K |
| 2026-02-02 | Parker Geoffrey M. | officer: CHIEF FINANCIAL OFFICER | A-Award | 539,072 | $1.87 | $1.0M |
| 2026-02-02 | Parker Geoffrey M. | officer: CHIEF FINANCIAL OFFICER | A-Award | 152,480 | -- | -- |
| 2026-02-02 | Chang David D | director, officer: President and CEO | A-Award | 1,387,931 | $1.87 | $2.6M |
| 2026-02-02 | Chang David D | director, officer: President and CEO | A-Award | 392,586 | -- | -- |
| 2026-02-02 | Parker Geoffrey M. | officer: CHIEF FINANCIAL OFFICER | SELL | 24,001 | $1.76 | $42K |
| 2026-02-02 | Douglas Earl Martin | officer: SVP, General Counsel | SELL | 22,900 | $1.76 | $40K |
| 2026-02-02 | Yoshiyama Annie | officer: SVP, Finance | SELL | 4,167 | $1.72 | $7K |
| 2026-02-02 | Yoshiyama Annie | officer: SVP, Finance | A-Award | 50,827 | -- | -- |
| 2026-02-02 | Roberts Zachary | officer: EVP of R&D | A-Award | 718,763 | $1.87 | $1.3M |
| 2026-02-02 | Roberts Zachary | officer: EVP of R&D | SELL | 35,700 | $1.77 | $63K |
| 2026-02-02 | Roberts Zachary | officer: EVP of R&D | A-Award | 203,307 | -- | -- |
| 2026-02-02 | Belldegrun Arie | director | A-Award | 929,913 | $1.87 | $1.7M |
| 2026-02-02 | Belldegrun Arie | director | A-Award | 263,033 | -- | -- |
| 2026-02-02 | Beneski Benjamin Machinas | officer: SVP, Chief Technical Officer | A-Award | 373,757 | $1.87 | $699K |
| 2026-02-02 | Douglas Earl Martin | officer: SVP, General Counsel | A-Award | 539,072 | $1.87 | $1.0M |
| 2026-02-02 | Douglas Earl Martin | officer: SVP, General Counsel | A-Award | 152,480 | -- | -- |
| 2026-02-02 | Yoshiyama Annie | officer: SVP, Finance | A-Award | 179,691 | $1.87 | $336K |